{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:30:35Z","timestamp":1761093035632,"version":"build-2065373602"},"reference-count":76,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.urolonc.2021.05.021","type":"journal-article","created":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T18:15:44Z","timestamp":1625163344000},"page":"569-576","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["A 25-year perspective on advances in an understanding of the biology, evaluation, treatment and future directions\/challenges of penile cancer"],"prefix":"10.1016","volume":"39","author":[{"given":"Timothy A.","family":"Masterson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott T.","family":"Tagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.urolonc.2021.05.021_bib0001","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S1470-2045(18)30682-X","article-title":"Prevalence of human papillomavirus DNA and p16INK4a in penile cancer and penile intraepithelial neoplasia: a systematic review and meta-analysis","volume":"20","author":"Olesen","year":"2019","journal-title":"Lancet Oncol"},{"issue":"10","key":"10.1016\/j.urolonc.2021.05.021_bib0002","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1158\/1055-9965.EPI-18-0322","article-title":"Prognostic significance of HPV and p16 status in men diagnosed with penile cancer: a systematic review and meta-analysis","volume":"27","author":"Sand","year":"2018","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"4","key":"10.1016\/j.urolonc.2021.05.021_bib0003","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.clgc.2015.12.019","article-title":"Clinical significance of p53 and p16(ink4a) status in a contemporary North American penile carcinoma cohort","volume":"14","author":"Zargar-Shoshtari","year":"2016","journal-title":"Clin Genitourin Cancer"},{"issue":"1","key":"10.1016\/j.urolonc.2021.05.021_bib0004","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1056\/NEJMoa0912217","article-title":"Human papillomavirus and survival of patients with oropharyngeal cancer","volume":"363","author":"Ang","year":"2010","journal-title":"N Engl J Med"},{"issue":"20","key":"10.1016\/j.urolonc.2021.05.021_bib0005","first-page":"S2588","article-title":"Association between human papillomavirus infection and outcome of perioperative nodal radiotherapy for penile carcinoma","volume":"30176-0","author":"Bandini","year":"2020","journal-title":"Eur Urol Oncol"},{"issue":"7587","key":"10.1016\/j.urolonc.2021.05.021_bib0006","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nature16481","article-title":"Structure of the E6\/E6AP\/p53 complex required for HPV-mediated degradation of p53","volume":"529","author":"Martinez-Zapien","year":"2016","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.urolonc.2021.05.021_bib0007","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1093\/infdis\/jix057","article-title":"Prevalence of genital human papillomavirus in males, United States, 2013-2014","volume":"215","author":"Gargano","year":"2017","journal-title":"J Infect Dis"},{"issue":"8","key":"10.1016\/j.urolonc.2021.05.021_bib0008","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1056\/NEJMsa0707052","article-title":"Health and economic implications of HPV vaccination in the United States","volume":"359","author":"Kim","year":"2008","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.urolonc.2021.05.021_bib0009","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/00001648-200211000-00006","article-title":"The theoretical population-level impact of a prophylactic human papilloma virus vaccine","volume":"13","author":"Hughes","year":"2002","journal-title":"Epidemiology"},{"key":"10.1016\/j.urolonc.2021.05.021_bib0010","doi-asserted-by":"crossref","first-page":"h2016","DOI":"10.1136\/bmj.h2016","article-title":"Direct benefit of vaccinating boys along with girls against oncogenic human papillomavirus: bayesian evidence synthesis","volume":"350","author":"Bogaards","year":"2015","journal-title":"BMJ"},{"issue":"13","key":"10.1016\/j.urolonc.2021.05.021_bib0011","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1056\/NEJMoa0802556","article-title":"Male circumcision for the prevention of HSV-2 and HPV infections and syphilis","volume":"360","author":"Tobian","year":"2009","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.urolonc.2021.05.021_bib0012","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/0090-4295(94)90189-9","article-title":"Ultrasound in squamous cell carcinoma of the penis; a useful addition to clinical staging? A comparison of ultrasound with histopathology","volume":"43","author":"Horenblas","year":"1994","journal-title":"Urology"},{"issue":"2","key":"10.1016\/j.urolonc.2021.05.021_bib0013","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0094-0143(21)00388-8","article-title":"Recent advances in imaging studies for staging of penile and urethral carcinoma","volume":"19","author":"Vapnek","year":"1992","journal-title":"Urol Clin North Am"},{"issue":"6","key":"10.1016\/j.urolonc.2021.05.021_bib0014","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1046\/j.1464-410X.2003.04119.x","article-title":"A comparison of physical examination and imaging in determining the extent of primary penile carcinoma","volume":"91","author":"Lont","year":"2003","journal-title":"BJU Int"},{"issue":"6","key":"10.1016\/j.urolonc.2021.05.021_bib0015","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.urology.2004.01.008","article-title":"Magnetic resonance imaging combined with artificial erection for local staging of penile cancer","volume":"63","author":"Scardino","year":"2004","journal-title":"Urology"},{"issue":"3","key":"10.1016\/j.urolonc.2021.05.021_bib0016","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/bju.13041","article-title":"The accuracy of magnetic resonance imaging (MRI) in predicting the invasion of the tunica albuginea and the urethra during the primary staging of penile cancer","volume":"117","author":"Hanchanale","year":"2016","journal-title":"BJU Int"},{"issue":"20","key":"10.1016\/j.urolonc.2021.05.021_bib0017","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1200\/JCO.2008.20.6870","article-title":"Two-center evaluation of dynamic sentinel node biopsy for squamous cell carcinoma of the penis","volume":"27","author":"Leijte","year":"2009","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.urolonc.2021.05.021_bib0018","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1097\/RLU.0b013e318238f6ea","article-title":"Accuracy of 18F-FDG PET\/CT for diagnosing inguinal lymph node involvement in penile squamous cell carcinoma: systematic review and meta-analysis of the literature","volume":"37","author":"Sadeghi","year":"2012","journal-title":"Clin Nucl Med"},{"issue":"5","key":"10.1016\/j.urolonc.2021.05.021_bib0019","doi-asserted-by":"crossref","first-page":"594","DOI":"10.6004\/jnccn.2013.0075","article-title":"National comprehensive cancer network. penile cancer: clinical practice guidelines in oncology","volume":"11","author":"Clark","year":"2013","journal-title":"J Natl Compr Canc Netw"},{"issue":"30","key":"10.1016\/j.urolonc.2021.05.021_bib0020","doi-asserted-by":"crossref","first-page":"48600","DOI":"10.18632\/oncotarget.9375","article-title":"Clinical value of fluorine-18 2-fluoro-2-deoxy-D-glucose positron emission tomography\/computed tomography in penile cancer","volume":"7","author":"Zhang","year":"2016","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.urolonc.2021.05.021_bib0021","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1093\/ajcp\/100.4.428","article-title":"Prognostic value of proliferating cell nuclear antigen index in gastric stromal tumors. Correlation with mitotic count and clinical outcome","volume":"100","author":"Amin","year":"1993","journal-title":"Am J Clin Pathol"},{"issue":"3","key":"10.1016\/j.urolonc.2021.05.021_bib0022","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.juro.2008.05.011","article-title":"Evaluation of current TNM classification of penile carcinoma","volume":"180","author":"Leijte","year":"2008","journal-title":"J Urol"},{"issue":"5","key":"10.1016\/j.urolonc.2021.05.021_bib0023","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/bju.12677","article-title":"Development and external validation of a prognostic tool for prediction of cancer-specific mortality after complete loco-regional pathological staging for squamous cell carcinoma of the penis","volume":"116","author":"Sun","year":"2015","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2021.05.021_bib0024","doi-asserted-by":"crossref","unstructured":"Li K, Sun J, Wei X, Wu G, Wang F, Fan C, et al. Prognostic value of lymphovascular invasion in patients with squamous cell carcinoma of the penis following surgery. BMC Cancer. 2019;19(1):476. https:\/\/doi.org\/10.1186\/s12885-019-5714-1.","DOI":"10.1186\/s12885-019-5714-1"},{"issue":"4","key":"10.1016\/j.urolonc.2021.05.021_bib0025","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.juro.2013.10.140","article-title":"The relationship between characteristics of inguinal lymph nodes and pelvic lymph node involvement in penile squamous cell carcinoma: a single institution experience","volume":"191","author":"Lughezzani","year":"2014","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2021.05.021_bib0026","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.radonc.2019.12.021","article-title":"Radical (chemo)radiotherapy in oropharyngeal squamous cell carcinoma: Comparison of TNM 7th and 8th staging systems","volume":"145","author":"De Felice","year":"2020","journal-title":"Radiother Oncol"},{"issue":"3","key":"10.1016\/j.urolonc.2021.05.021_bib0027","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1097\/JU.0000000000000584","article-title":"Prognosis of the 8th TNM staging system for penile cancer and refinement of prognostication by incorporating high risk human papillomavirus status","volume":"203","author":"Wang","year":"2020","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/j.urolonc.2021.05.021_bib0029","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/0090-4295(84)90138-9","article-title":"Sentinel lymph node biopsy for staging penile cancer","volume":"23","author":"Fowler","year":"1984","journal-title":"Urology"},{"issue":"5","key":"10.1016\/j.urolonc.2021.05.021_bib0030","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/S0022-5347(17)55633-5","article-title":"Unreliability of sentinel lymph node biopsy for staging penile carcinoma","volume":"124","author":"Perinetti","year":"1980","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/j.urolonc.2021.05.021_bib0031","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/0090-4295(86)90004-X","article-title":"Cabanas approach: is sentinel node biopsy reliable for staging penile carcinoma?","volume":"28","author":"Wespes","year":"1986","journal-title":"Urology"},{"issue":"2","key":"10.1016\/j.urolonc.2021.05.021_bib0032","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0094-0143(21)00389-X","article-title":"Anatomy and biopsy of sentinel lymph nodes","volume":"19","author":"Cabanas","year":"1992","journal-title":"Urol Clin North Am"},{"issue":"6","key":"10.1016\/j.urolonc.2021.05.021_bib0033","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1159\/000472826","article-title":"Cancer of the penis. experience at the norwegian radium hospital 1974-1985","volume":"13","author":"Foss\u00e5","year":"1987","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.urolonc.2021.05.021_bib0034","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0022-5347(17)44718-5","article-title":"Treatment of carcinoma of the penis: the case for primary lymphadenectomy","volume":"136","author":"McDougal","year":"1986","journal-title":"J Urol"},{"issue":"6","key":"10.1016\/j.urolonc.2021.05.021_bib0035","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1016\/S0022-5347(01)66671-0","article-title":"Sentinel lymph node dissection for penile carcinoma: the M. D. Anderson cancer center experience","volume":"154","author":"Pettaway","year":"1995","journal-title":"J Urol"},{"issue":"22","key":"10.1016\/j.urolonc.2021.05.021_bib0036","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1001\/jama.1996.03540220042028","article-title":"Lymphatic mapping and sentinel node biopsy in the patient with breast cancer","volume":"276","author":"Albertini","year":"1996","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.urolonc.2021.05.021_bib0037","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1200\/JCO.1999.17.3.976","article-title":"Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients","volume":"17","author":"Gershenwald","year":"1999","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.urolonc.2021.05.021_bib0038","first-page":"163","article-title":"Intraoperative lymphatic mapping for vulvar cancer","volume":"84","author":"Levenback","year":"1994","journal-title":"Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.urolonc.2021.05.021_bib0039","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1001\/archsurg.1992.01420040034005","article-title":"Technical details of intraoperative lymphatic mapping for early stage melanoma","volume":"127","author":"Morton","year":"1992","journal-title":"Arch Surg"},{"issue":"6","key":"10.1016\/j.urolonc.2021.05.021_bib0040","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1097\/01.ju.0000124485.34430.15","article-title":"How to avoid false-negative dynamic sentinel node procedures in penile carcinoma","volume":"171","author":"Kroon","year":"2004","journal-title":"J Urol"},{"issue":"6","key":"10.1016\/j.urolonc.2021.05.021_bib0041","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1016\/j.juro.2007.01.125","article-title":"Preoperative lymphoscintigraphy and dynamic sentinel node biopsy for staging penile cancer: results with pathological correlation","volume":"177","author":"Spiess","year":"2007","journal-title":"J Urol"},{"issue":"6","key":"10.1016\/j.urolonc.2021.05.021_bib0042","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1007\/s00345-019-02866-9","article-title":"Albersen M; and in collaboration with the European reference network for rare urogenital diseases and complex conditions (eUROGEN)","volume":"38","author":"Vanthoor","year":"2020","journal-title":"World J Urol"},{"issue":"5","key":"10.1016\/j.urolonc.2021.05.021_bib0043","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1097\/MOU.0000000000000803","article-title":"Volume outcome relationship in penile cancer: a systematic review","volume":"30","author":"Quhal","year":"2020","journal-title":"Curr Opin Urol"},{"key":"10.1016\/j.urolonc.2021.05.021_bib0044","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.urology.2015.12.058","article-title":"Centralization of penile cancer management in the united states: a combined analysis of the American board of urology and national cancer data base","volume":"90","author":"Matulewicz","year":"2016","journal-title":"Urology"},{"year":"1997","series-title":"Urology","author":"Cambell's","key":"10.1016\/j.urolonc.2021.05.021_bib0045"},{"issue":"3","key":"10.1016\/j.urolonc.2021.05.021_bib0046","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1046\/j.1464-410x.2000.00413.x","article-title":"The histological extent of the local spread of carcinoma of the penis and its therapeutic implications","volume":"85","author":"Agrawal","year":"2000","journal-title":"BJU Int"},{"issue":"1","key":"10.1016\/j.urolonc.2021.05.021_bib0047","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eururo.2004.03.007","article-title":"European association of urology. eau guidelines on penile cancer","volume":"46","author":"Solsona","year":"2004","journal-title":"Eur Urol"},{"issue":"4","key":"10.1016\/j.urolonc.2021.05.021_bib0048","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/bju.14222","article-title":"A study into the association between local recurrence rates and surgical resection margins in organ-sparing surgery for penile squamous cell cancer","volume":"122","author":"Sri","year":"2018","journal-title":"BJU Int"},{"issue":"4","key":"10.1016\/j.urolonc.2021.05.021_bib0049","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.urolonc.2017.07.025","article-title":"Predictive factors for local recurrence after glansectomy and neoglans reconstruction for penile squamous cell carcinoma","volume":"36","author":"Albersen","year":"2018","journal-title":"Urol Oncol"},{"issue":"5","key":"10.1016\/j.urolonc.2021.05.021_bib0050","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.urology.2014.11.048","article-title":"Oncologic outcomes of penile cancer treatment at a UK supraregional center","volume":"85","author":"Veeratterapillay","year":"2015","journal-title":"Urology"},{"issue":"1","key":"10.1016\/j.urolonc.2021.05.021_bib0051","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.juro.2013.12.038","article-title":"Penile sparing surgery for penile cancer-does it affect survival?","volume":"192","author":"Djajadiningrat","year":"2014","journal-title":"J Urol"},{"issue":"6","key":"10.1016\/j.urolonc.2021.05.021_bib0052","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1097\/01.ju.0000067361.81295.a2","article-title":"Combined laser treatment for penile carcinoma: results after long-term followup","volume":"169","author":"Windahl","year":"2003","journal-title":"J Urol"},{"issue":"5","key":"10.1016\/j.urolonc.2021.05.021_bib0053","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1016\/j.juro.2007.07.039","article-title":"Mohs micrographic surgery for penile cancer: management and long-term followup","volume":"178","author":"Shindel","year":"2007","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.urolonc.2021.05.021_bib0054","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.eururo.2010.09.039","article-title":"Glans resurfacing for the treatment of carcinoma in situ of the penis: surgical technique and outcomes","volume":"59","author":"Shabbir","year":"2011","journal-title":"Eur Urol"},{"issue":"4","key":"10.1016\/j.urolonc.2021.05.021_bib0055","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/S0022-5347(05)66450-6","article-title":"Tumor stage, vascular invasion and the percentage of poorly differentiated cancer: independent prognosticators for inguinal lymph node metastasis in penile squamous cancer","volume":"165","author":"Slaton","year":"2001","journal-title":"J Urol"},{"issue":"3","key":"10.1016\/j.urolonc.2021.05.021_bib0056","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/MOU.0000000000000591","article-title":"Important surgical concepts and techniques in inguinal lymph node dissection","volume":"29","author":"Chipollini","year":"2019","journal-title":"Curr Opin Urol"},{"issue":"1","key":"10.1016\/j.urolonc.2021.05.021_bib0057","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.eururo.2014.10.017","article-title":"EAU guidelines on penile cancer: 2014 update","volume":"67","author":"Hakenberg","year":"2015","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.urolonc.2021.05.021_bib0058","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.juro.2006.10.060","article-title":"Pelvic lymph node dissection for penile carcinoma: extent of inguinal lymph node involvement as an indicator for pelvic lymph node involvement and survival","volume":"177","author":"Lont","year":"2007","journal-title":"J Urol"},{"issue":"3","key":"10.1016\/j.urolonc.2021.05.021_bib0059","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.juro.2015.03.090","article-title":"Establishing criteria for bilateral pelvic lymph node dissection in the management of penile cancer: lessons learned from an international multicenter collaboration","volume":"194","author":"Zargar-Shoshtari","year":"2015","journal-title":"J Urol"},{"issue":"6","key":"10.1016\/j.urolonc.2021.05.021_bib0060","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1097\/MOU.0000000000000447","article-title":"Advancements in staging and imaging for penile cancer","volume":"27","author":"Ottenhof","year":"2017","journal-title":"Curr Opin Urol"},{"issue":"6","key":"10.1016\/j.urolonc.2021.05.021_bib0061","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1016\/S0022-5347(05)68815-5","article-title":"Cisplatin, methotrexate and bleomycin for the treatment of carcinoma of the penis: a southwest oncology group study","volume":"161","author":"Haas","year":"1999","journal-title":"J Urol"},{"issue":"24","key":"10.1016\/j.urolonc.2021.05.021_bib0062","doi-asserted-by":"crossref","first-page":"3851","DOI":"10.1200\/JCO.2010.29.5477","article-title":"Neoadjuvant paclitaxel, ifosfamide, and cisplatin chemotherapy for metastatic penile cancer: a phase II study","volume":"28","author":"Pagliaro","year":"2010","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.urolonc.2021.05.021_bib0063","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.urology.2014.12.049","article-title":"Treatment for metastatic penile cancer after first-line chemotherapy failure: analysis of response and survival outcomes","volume":"85","author":"Wang","year":"2015","journal-title":"Urology"},{"issue":"7","key":"10.1016\/j.urolonc.2021.05.021_bib0064","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1093\/annonc\/mdn149","article-title":"EORTC Genito-Urinary Tract Cancer Group. A phase II multicentre study of irinotecan (CPT 11) in combination with cisplatin (CDDP) in metastatic or locally advanced penile carcinoma (EORTC PROTOCOL 30992)","volume":"19","author":"Theodore","year":"2008","journal-title":"Ann Oncol"},{"issue":"10","key":"10.1016\/j.urolonc.2021.05.021_bib0065","doi-asserted-by":"crossref","first-page":"4664","DOI":"10.1177\/0300060519863546","article-title":"A phase II trial of cabazitaxel as second line chemotherapy in relapsed locally advanced and\/or metastatic carcinoma of the penis","volume":"47","author":"Challapalli","year":"2019","journal-title":"J Int Med Res"},{"issue":"suppl 6S","key":"10.1016\/j.urolonc.2021.05.021_bib0066","article-title":"A phase II trial of Vinflunine chemotherapy in locally-advanced and metastatic carcinoma of the penis (CRUK\/12\/021)","volume":"36","author":"Pickering","year":"2018","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1016\/j.urolonc.2021.05.021_bib0067","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/s41585-020-0359-z","article-title":"Understanding genomics and the immune environment of penile cancer to improve therapy","volume":"17","author":"Aydin","year":"2020","journal-title":"Nat Rev Urol"},{"issue":"7","key":"10.1016\/j.urolonc.2021.05.021_bib0068","doi-asserted-by":"crossref","first-page":"e80","DOI":"10.1097\/PAS.0000000000001477","article-title":"Report from the International Society of Urological Pathology (ISUP) consultation conference on molecular pathology of urogenital cancers v: recommendations on the use of immunohistochemical and molecular biomarkers in penile cancer","volume":"44","author":"Canete-Portillo","year":"2020","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.urolonc.2021.05.021_bib0069","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.juro.2018.09.056","article-title":"Comparative genomic profiling of refractory and metastatic penile and nonpenile cutaneous squamous cell carcinoma: implications for selection of systemic therapy","volume":"201","author":"Jacob","year":"2019","journal-title":"J Urol"},{"issue":"suppl 6","key":"10.1016\/j.urolonc.2021.05.021_bib0070","article-title":"Clinically advanced penile (pSCC) and male urethral (uSCC) squamous cell carcinoma: A comparative genomic profiling (CGP) study","volume":"39","author":"Spiess","year":"2021","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.urolonc.2021.05.021_bib0071","doi-asserted-by":"crossref","first-page":"e80","DOI":"10.1016\/j.clgc.2018.09.012","article-title":"Impact of PI3K-AKT-mTOR signaling pathway up-regulation on prognosis of penile squamous-cell carcinoma: results from a tissue microarray study and review of the literature","volume":"17","author":"Azizi","year":"2019","journal-title":"Clin Genitourin Cancer"},{"issue":"161","key":"10.1016\/j.urolonc.2021.05.021_bib0072","article-title":"Cytosolic phosphorylated EGFR is predictive of recurrence in early stage penile cancer patients: a retropective study","volume":"11","author":"Di Lorenzo","year":"2013","journal-title":"J Transl Med"},{"issue":"6","key":"10.1016\/j.urolonc.2021.05.021_bib0073","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1111\/bju.12450","article-title":"Epidermal growth factor receptor-targeted therapy in locally advanced or metastatic squamous cell carcinoma of the penis","volume":"113","author":"Carthon","year":"2014","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2021.05.021_bib0074","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.humpath.2016.09.003","article-title":"Immune-checkpoint status in penile squamous cell carcinoma: a North American cohort","volume":"59","author":"Cocks","year":"2017","journal-title":"Hum Pathol"},{"issue":"9","key":"10.1016\/j.urolonc.2021.05.021_bib0075","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1093\/annonc\/mdw216","article-title":"Frequent PD-L1 expression in primary and metastatic penile squamous cell carcinoma: potential opportunities for immunotherapeutic approaches","volume":"27","author":"Udager","year":"2016","journal-title":"Ann Oncol"},{"issue":"2-3","key":"10.1016\/j.urolonc.2021.05.021_bib0076","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1159\/000495251","article-title":"No evidence of microsatellite instability and loss of mismatch-repair-protein expression in squamous cell carcinoma of the penis","volume":"86","author":"Stoehr","year":"2019","journal-title":"Pathobiology"},{"issue":"1","key":"10.1016\/j.urolonc.2021.05.021_bib0077","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1038\/s41467-020-15980-9","article-title":"Effective combinatorial immunotherapy for penile squamous cell carcinoma","volume":"11","author":"Huang","year":"2020","journal-title":"Nat Commun"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143921002295?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143921002295?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:21:18Z","timestamp":1761042078000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143921002295"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":76,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S1078143921002295"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2021.05.021","relation":{},"ISSN":["1078-1439"],"issn-type":[{"type":"print","value":"1078-1439"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A 25-year perspective on advances in an understanding of the biology, evaluation, treatment and future directions\/challenges of penile cancer","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2021.05.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}